These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3798400)
1. Placental transfer of Org 10172, a low-molecular weight heparinoid, in the awake late-pregnant guinea pig. Peeters LL; Hobbelen PM; Verkeste CM; Vogel GM; Hasenack HG; Meuleman DG; Wallenburg HC Thromb Res; 1986 Nov; 44(3):277-83. PubMed ID: 3798400 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients. ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213 [TBL] [Abstract][Full Text] [Related]
3. Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model. Saivin S; Giroux M; Dumas JC; Faure F; Rekik L; Grandjean H; Boneu B; Houin G Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42(3):221-5. PubMed ID: 1663463 [TBL] [Abstract][Full Text] [Related]
4. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247 [TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate. ten Cate H; Henny CP; ten Cate JW; Büller HR; Dabhoiwala NF Thromb Haemost; 1987 Feb; 57(1):92-6. PubMed ID: 2438799 [TBL] [Abstract][Full Text] [Related]
6. Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid Org 10172 or heparin to rats. Hobbelen PM; Vogel GM; Meuleman DG Thromb Res; 1987 Dec; 48(5):549-58. PubMed ID: 3481660 [TBL] [Abstract][Full Text] [Related]
7. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. Sferruzzi-Perri AN; Owens JA; Standen P; Taylor RL; Heinemann GK; Robinson JS; Roberts CT Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E668-76. PubMed ID: 17062842 [TBL] [Abstract][Full Text] [Related]
8. Low molecular weight dermatan sulphate (Desmin 370) does not cross the ovine placenta. Dawes J; Lumbers ER Br J Haematol; 1993 May; 84(1):90-4. PubMed ID: 8338783 [TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers. Stiekema JC; Wijnand HP; Van Dinther TG; Moelker HC; Dawes J; Vinchenzo A; Toeberich H Br J Clin Pharmacol; 1989 Jan; 27(1):39-48. PubMed ID: 2468354 [TBL] [Abstract][Full Text] [Related]
10. Interaction of the combined medication with the new low-molecular-weight heparinoid Lomoparan (Org 10172) and acenocoumarol. Stiekema JC; de Boer A; Danhof M; Kroon C; Broekmans AW; van Dinther TG; Voerman J; Breimer DD Haemostasis; 1990; 20(3):136-46. PubMed ID: 1696921 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Greinacher A; Eckhardt T; Mussmann J; Mueller-Eckhardt C Thromb Res; 1993 Jul; 71(2):123-6. PubMed ID: 7689764 [TBL] [Abstract][Full Text] [Related]
12. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Biller J; Massey EW; Marler JR; Adams HP; Davis JN; Bruno A; Henriksen RA; Linhardt RJ; Goldstein LB; Alberts M Neurology; 1989 Feb; 39(2 Pt 1):262-5. PubMed ID: 2464774 [TBL] [Abstract][Full Text] [Related]
13. The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172. De Boer A; Stiekema JC; Danhof M; Breimer DD Br J Clin Pharmacol; 1991 Jul; 32(1):23-9. PubMed ID: 1716140 [TBL] [Abstract][Full Text] [Related]
14. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Bradbrook ID; Magnani HN; Moelker HC; Morrison PJ; Robinson J; Rogers HJ; Spector RG; Van Dinther T; Wijnand H Br J Clin Pharmacol; 1987 Jun; 23(6):667-75. PubMed ID: 3606928 [TBL] [Abstract][Full Text] [Related]
15. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment. Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791 [TBL] [Abstract][Full Text] [Related]
16. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis. Von Bonsdorff M; Stiekema J; Harjanne A; Alapiessa U Int J Artif Organs; 1990 Feb; 13(2):103-8. PubMed ID: 2347652 [TBL] [Abstract][Full Text] [Related]
17. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Magnani HN; Hull RD; Gent M Lancet; 1987 Mar; 1(8532):523-6. PubMed ID: 2434815 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis. Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351 [TBL] [Abstract][Full Text] [Related]
19. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604 [TBL] [Abstract][Full Text] [Related]